TG THERAPEUTICS, INC. (TGTX) › Shareholders' EquityTG THERAPEUTICS, INC. (TGTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: $9.62M2012: $15.55M2020: $519.35M2021: $237.15M2022: $58.59M2023: $160.50M2024: $222.36M2025: $648.02M$648.02M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$648.02M+191.4%2024$222.36M+38.5%2023$160.50M+174.0%2022$58.59M-75.3%2021$237.15M-54.3%2020$519.35M—2012$15.55M+61.6%2011$9.62M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share